CAR-T Cell Therapy: Current Uses and Future Possibilities

  Рет қаралды 3,679

Mayo Clinic

Mayo Clinic

8 ай бұрын

This webinar recording provides a thorough summary of the current and future applications of CAR-T cell therapy along with efforts to better manage patients and selection criteria of the appropriate treatment.
The webinar is moderated by . Panelists include Dr. Kharfan, Dr. Paronndo, and Dr. Murhty from the Mayo Clinic.
From Mayo Clinic to your inbox, sign-up for free: mayocl.in/3e71zfi
Visit Mayo Clinic: mayocl.in/2COVmlm
Like Mayo Clinic on Facebook: / mayoclinic
Follow Mayo Clinic on Instagram: / mayoclinic
Follow Mayo Clinic on Twitter: / mayoclinic

Пікірлер
CAR T Cell Therapy for Relapsed Lymphoma: Journey from being a Patient to a Survivor
49:10
International Academy for Clinical Hematology IACH
Рет қаралды 302
Update in Multiple Myeloma
44:53
Dana-Farber Cancer Institute
Рет қаралды 12 М.
Bike Vs Tricycle Fast Challenge
00:43
Russo
Рет қаралды 51 МЛН
Je peux le faire
00:13
Daniil le Russe
Рет қаралды 22 МЛН
Поветкин заставил себя уважать!
01:00
МИНУС БАЛЛ
Рет қаралды 5 МЛН
CAR T Cell Therapy in Lupus: Promises and Challenges Explored
1:32:57
Lupus Europe
Рет қаралды 2,3 М.
CAR T-cell Therapy: Lymphoma - The Good, The Bad, The Exciting
1:00:05
Engineering Better CAR T Cells: An Interview with CRI  STAR Yvonne Chen, PhD
16:43
Cancer Research Institute
Рет қаралды 4,8 М.
CAR T-Cells and Safety Signals
25:26
NEJM Group
Рет қаралды 702
CMC Considerations for CAR T Cell Product Development
29:42
U.S. Food and Drug Administration
Рет қаралды 11 М.
CAR-T Cells: Engineered Cancer Killers
11:18
Peter MacCallum Cancer Centre
Рет қаралды 134 М.
CAR T Cells in Multiple Myeloma
22:48
Dana-Farber Cancer Institute
Рет қаралды 968
A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister
1:03:49
HealthTree Foundation for Multiple Myeloma
Рет қаралды 9 М.
Saudi Arabia’s giant money pit: NEOM | If You’re Listening
13:28
ABC News In-depth
Рет қаралды 651 М.
Bike Vs Tricycle Fast Challenge
00:43
Russo
Рет қаралды 51 МЛН